Modus Therapeutics Initiates Phase 2A Study For Anemia
10 Dec 2025 //
PHARMIWEB
Modus Therapeutics Releases Q3 2025 Interim Report
26 Nov 2025 //
PHARMIWEB
Modus Therapeutics Receives Approval for Ph IIa CKD Clinical Trial
19 Nov 2024 //
PHARMAWEB
Modus mulls Phase II trials of sevuparin in anaemia
13 Jun 2023 //
CLINICAL TRIALS ARENA

Market Place
Sourcing Support